Telehealth

The use of telehealth technology by Florida licensed healthcare practitioners for the purpose of providing patient care within the state of Florida is not precluded by Florida law. Continue reading

2017 Legislation Impacting Your Profession

Click here to view a full list of bill summaries from the 2017 Florida Legislative Session that may impact your profession. Continue reading

State of Emergency Issued

Governor Scott issues an Executive Order declaring the opioid epidemic a state of emergency in Florida… Continue reading

Attention Pharmacists: Florida HB423

ARNP’s and PA’s, if you have questions regarding the Florida House Bill 423 and how it affects you, this free, informative webinar is for you! Continue reading

Imagineering the Future of Pharmacy Regulation

The boards of pharmacy will elect officers and members of the NABP Executive Committee, review and vote on NABP policies, and guide the direction of the Association Continue reading

Important Administrative Rule Update

Effective January 12, 2017 Florida Administrative Code, 64K-1.004 Management and Operation of Database has been amended requiring all pharmacies that DO NOT dispense controlled substances in or into this state submit a Notification of Exemption from Reporting (Form DH8016-PDMP). Exemptions … Continue reading

Bills That Go Into Effect January 1, 2017

SB 0422 Relating to Health Insurance Coverage For Opioids Health Insurance Coverage For Opioids; Providing that a health insurance policy that covers abuse-deterrent opioid analgesic drug products may impose a prior authorization requirement for an abuse-deterrent opioid analgesic drug product … Continue reading

DEA’s suspension of McKesson Corporation Retraction

Please see updated information about the DEA’s suspension of McKesson Corporation and controlled substances Continue reading

Medical Marijuana Update

For information please contact the office of compassionate use. Office of Compassionate Use Website: http://www.floridahealth.gov/programs-and-services/office-of-compassionate-use/ Main line: 850-245-4657

FDA meeting on September 20-21, 2016

On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of … Continue reading